Research Analysts Offer Predictions for Nukkleus Q2 Earnings

Nukkleus Inc. (NASDAQ:DFNSFree Report) – Equities research analysts at Noble Financial lifted their Q2 2026 earnings estimates for shares of Nukkleus in a research report issued to clients and investors on Tuesday, July 21st. Noble Financial analyst J. Gomes now forecasts that the company will earn ($3.11) per share for the quarter, up from their previous forecast of ($8.75). Noble Financial currently has a “Strong-Buy” rating on the stock. The consensus estimate for Nukkleus’ current full-year earnings is ($63.98) per share. Noble Financial also issued estimates for Nukkleus’ Q3 2026 earnings at ($2.70) EPS, Q4 2026 earnings at ($2.30) EPS, FY2026 earnings at ($4.21) EPS, FY2027 earnings at ($7.27) EPS and FY2028 earnings at ($2.18) EPS.

A number of other brokerages have also issued reports on DFNS. Wall Street Zen raised Nukkleus to a “sell” rating in a research note on Saturday. Weiss Ratings downgraded Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Nukkleus presently has a consensus rating of “Moderate Buy”.

Read Our Latest Stock Analysis on DFNS

Nukkleus Price Performance

Shares of Nukkleus stock opened at $4.35 on Thursday. The business has a 50 day simple moving average of $27.12 and a two-hundred day simple moving average of $142.18. Nukkleus has a 12 month low of $3.70 and a 12 month high of $1,948.75. The stock has a market capitalization of $3.31 million, a P/E ratio of -1.48 and a beta of -5.82. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.25 and a quick ratio of 0.21.

Nukkleus (NASDAQ:DFNSGet Free Report) last posted its quarterly earnings data on Wednesday, May 20th. The company reported ($142.50) earnings per share (EPS) for the quarter. The company had revenue of $3.65 million during the quarter.

Institutional Trading of Nukkleus

Several institutional investors have recently made changes to their positions in the company. GM Advisory Group LLC acquired a new position in Nukkleus in the fourth quarter valued at approximately $56,000. BNP Paribas Financial Markets acquired a new stake in Nukkleus during the second quarter worth $56,000. Price T Rowe Associates Inc. MD acquired a new stake in Nukkleus during the fourth quarter worth $57,000. Millennium Management LLC purchased a new stake in Nukkleus in the fourth quarter valued at $60,000. Finally, State Street Corp raised its position in Nukkleus by 70.7% in the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after purchasing an additional 7,400 shares during the period. Hedge funds and other institutional investors own 12.47% of the company’s stock.

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Featured Articles

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.